中华医学杂志（英文版）2021，Vol.134Issue(8)：999-1000,2.DOI:10.1097/CM9.0000000000001235
Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
Fei Teng 1Jin-Min Peng 2Qian Wang 3Xin-Lun Tian 4Zhen Huo 5Li Weng2
作者信息
- 1. Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
- 2. Department of Medical Intensive Care Unit, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730,China
- 3. Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
- 4. Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,100730, Beijing, China
- 5. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
- 折叠
引用本文复制引用
Fei Teng,Jin-Min Peng,Qian Wang,Xin-Lun Tian,Zhen Huo,Li Weng..Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody[J].中华医学杂志（英文版）,2021,134(8):999-1000,2.
